OKUR insider trading
OnKure Therapeutics, Inc.
In the past 36 days, 2 insiders sold $1K.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Jason A. Leverone Chief Financial Officer |
$898 302 sh @ $2.97 |
−1.6% | Not pre-scheduled | Sep 21, 2026 Filed Sep 23, 2026 |
Nicholas A Saccomano President and CEO |
$259 87 sh @ $2.97 |
−0.8% | Not pre-scheduled | Sep 21, 2026 Filed Sep 23, 2026 |